![Barry Porter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Barry Porter
No open positions remaining
Profile
Barry Porter was the Chief Executive Officer of ReOx Ltd. and Union Life Sciences Ltd. He was also a Non-Executive Director at Oxford Drug Design Ltd. and Avacta Group Plc from 2009 to 2011.
Additionally, he served as a Director at IR 2018 Ltd. from 2013 to 2018.
Former positions of Barry Porter
| Companies | Position | End |
|---|---|---|
IR 2018 Ltd.
 IR 2018 Ltd. Miscellaneous Commercial ServicesCommercial Services Develops human proteins for the treatment of rheumatoid arthritis and related diseases | Director/Board Member | 04/01/2018 |
| AVACTA GROUP PLC | Director/Board Member | 17/03/2011 |
Union Life Sciences Ltd.
 Union Life Sciences Ltd. BiotechnologyHealth Technology Engages in research and development in biotechnology | Chief Executive Officer | - |
Oxford Drug Design Ltd.
 Oxford Drug Design Ltd. Packaged SoftwareTechnology Services Develops software solutions used for computational methods to discover new leads for drugs | Director/Board Member | - |
ReOx Ltd.
 ReOx Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | President | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Oxford Drug Design Ltd.
Oxford Drug Design Ltd. Packaged SoftwareTechnology Services Develops software solutions used for computational methods to discover new leads for drugs | Technology Services |
ReOx Ltd.
ReOx Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
Avacta Group Plc
 Avacta Group Plc Miscellaneous Commercial ServicesCommercial Services Engages in the business of healthcare technology and consumables | Commercial Services |
IR 2018 Ltd.
IR 2018 Ltd. Miscellaneous Commercial ServicesCommercial Services Develops human proteins for the treatment of rheumatoid arthritis and related diseases | Commercial Services |
Union Life Sciences Ltd.
Union Life Sciences Ltd. BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
- Stock Market
- Insiders
- Barry Porter
